Regeneron (NASDAQ: REGN) reported Q4 EPS of $11.86, $1.09 better than the analyst estimate of $10.77. Revenue for the quarter came in at $3.43 billion versus the consensus estimate of $3.3 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.